Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024
The prevalence of xylazine in samples containing opioids has increased in New York City from November 2021 through December 2024. Drug checking can monitor changes in the local drug supply and inform existing harm reduction efforts.
Authors
- Andrew J. Trinidad (ORCID: https://orcid.org/0009-0008-8938-2207)
- Jeffery Sauer (ORCID: https://orcid.org/0000-0002-8581-6919)
- Izza Zaidi (ORCID: https://orcid.org/0000-0001-7898-4386)
- Alex Harocopos (ORCID: https://orcid.org/0000-0002-4650-762X)
- Yarelix Estrada (ORCID: https://orcid.org/0009-0006-8199-1089)
- Hannah Helmy
Institutions
- New York City Department of Health and Mental Hygiene (US)
Publication Details
- Journal
- Harm Reduction Journal
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1186/s12954-025-01237-5
- Citations
- 4
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.51
Funders
- Centers for Disease Control and Prevention Foundation
- Centers for Disease Control and Prevention